JP2006514981A5 - - Google Patents

Download PDF

Info

Publication number
JP2006514981A5
JP2006514981A5 JP2004571002A JP2004571002A JP2006514981A5 JP 2006514981 A5 JP2006514981 A5 JP 2006514981A5 JP 2004571002 A JP2004571002 A JP 2004571002A JP 2004571002 A JP2004571002 A JP 2004571002A JP 2006514981 A5 JP2006514981 A5 JP 2006514981A5
Authority
JP
Japan
Prior art keywords
independently
alkyl
moiety
following structure
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004571002A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006514981A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/038471 external-priority patent/WO2004050711A2/en
Publication of JP2006514981A publication Critical patent/JP2006514981A/ja
Publication of JP2006514981A5 publication Critical patent/JP2006514981A5/ja
Pending legal-status Critical Current

Links

JP2004571002A 2002-12-03 2003-12-03 Gp120特異抗原、その結合体;その調製と使用のための方法 Pending JP2006514981A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US43082202P 2002-12-03 2002-12-03
US50016103P 2003-09-04 2003-09-04
US50070803P 2003-09-05 2003-09-05
PCT/US2003/038471 WO2004050711A2 (en) 2002-12-03 2003-12-03 Gp120 specific antigens, conjugates thereof, methods for their preparation and uses thereof

Publications (2)

Publication Number Publication Date
JP2006514981A JP2006514981A (ja) 2006-05-18
JP2006514981A5 true JP2006514981A5 (https=) 2009-05-14

Family

ID=32475412

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004571002A Pending JP2006514981A (ja) 2002-12-03 2003-12-03 Gp120特異抗原、その結合体;その調製と使用のための方法

Country Status (6)

Country Link
US (1) US7531181B2 (https=)
EP (1) EP1569955A2 (https=)
JP (1) JP2006514981A (https=)
AU (1) AU2003302235A1 (https=)
CA (1) CA2508539A1 (https=)
WO (1) WO2004050711A2 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7854934B2 (en) 1999-08-20 2010-12-21 Sloan-Kettering Institute For Cancer Research Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof
US7824687B2 (en) * 1999-08-20 2010-11-02 Sloan-Kettering Institute For Cancer Research Clustered multi-antigenic carbohydrate constructs, methods for their preparation, and uses thereof
JP5111705B2 (ja) 1999-08-20 2013-01-09 スローン−ケッタリング インスティトュート フォア キャンサー リサーチ 新規な複合多糖、グリコアミノ酸、これらへの中間体、及びこれらの使用
WO2004050711A2 (en) 2002-12-03 2004-06-17 Sloan-Kettering Institute For Cancer Research Gp120 specific antigens, conjugates thereof, methods for their preparation and uses thereof
WO2005078443A1 (en) * 2004-02-13 2005-08-25 Inverness Medical Switzerland Gmbh Determination of infection by the immune response to a carbohydrate moiety
CA2601797A1 (en) * 2005-03-16 2006-09-21 University Of Oxford Mannose immunogens for hiv-1
EP1934605B1 (en) * 2005-09-22 2014-03-26 Prosci Incorporated Glycosylated polypeptides produced in yeast mutants and methods of use thereof
EP2010556B1 (en) 2006-04-11 2015-09-23 Sloan-Kettering Institute for Cancer Research Homogeneous erythropoietin and method for their preparation
TWI432448B (zh) * 2006-09-14 2014-04-01 Univ Duke 疫苗
JP2010516784A (ja) * 2007-01-29 2010-05-20 ユニバーシティ・オブ・オックスフォード 糖免疫原
ES2360334T3 (es) 2008-06-27 2011-06-03 Theranor Sprl Composiciones farmacéuticas de anticuerpos para enfermedades causadas por virus.
WO2010006343A2 (en) * 2008-07-11 2010-01-14 Sloan-Kettering Institute For Cancer Research Glycopeptide constructs and uses thereof
US20110136729A1 (en) * 2009-05-26 2011-06-09 Shien Lu Occidiofungin, a unique antifungal glycopeptide produced by a strain of burkholderia contaminans
WO2011026111A1 (en) 2009-08-31 2011-03-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Oral delivery of a vaccine to the large intestine to induce mucosal immunity
EP2556377B1 (en) 2010-04-08 2017-07-12 University of Pittsburgh - Of the Commonwealth System of Higher Education B-cell antigen presenting cell assay
CA2801922A1 (en) 2010-06-11 2011-12-15 Sloan-Kettering Institute For Cancer Research Multivalent glycopeptide constructs and uses thereof
WO2014085419A1 (en) 2012-11-29 2014-06-05 The Texas A&M University System Engineering the production of a conformational variant of occidiofungin that has enhanced inhibitory activity against fungal species
US10265374B2 (en) 2014-09-12 2019-04-23 Mississippi State University Occidiofungin formations and uses thereof
JP7005504B2 (ja) 2016-02-22 2022-01-21 ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー 生体分子の固定化方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL98845A0 (en) 1990-07-19 1992-07-15 Merck & Co Inc Coconjugate vaccines comprising immunogenic protein,hiv related peptides,and anionic moieties,their preparation and pharmaceutical compositions containing them
CA2059692C (en) 1991-01-28 2004-11-16 Peter J. Kniskern Pneumoccoccal polysaccharide conjugate vaccine
US6080725A (en) 1997-05-20 2000-06-27 Galenica Pharmaceuticals, Inc. Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof
DE69828507T2 (de) 1997-05-20 2006-01-05 Galenica Pharmaceuticals, Inc. Triterpene-saponin analoga mit adjuvans und immunostimulierender wirkung
EP1572963A4 (en) * 2002-10-11 2007-08-22 Univ Maryland Biotech Inst SYNTHETIC VACCINES CARBOHYDRATE BASE AGAINST HIV
WO2004050711A2 (en) 2002-12-03 2004-06-17 Sloan-Kettering Institute For Cancer Research Gp120 specific antigens, conjugates thereof, methods for their preparation and uses thereof
WO2004060915A2 (en) 2002-12-03 2004-07-22 Sloan-Kettering Institute For Cancer Research Prostate specific antigens, conjugates thereof, methods for their preparation and uses thereof.

Similar Documents

Publication Publication Date Title
JP2006514981A5 (https=)
Roy Recent developments in the rational design of multivalent glycoconjugates
Galan et al. Multivalent glyco (cyclo) peptides
Niederhafner et al. Glycopeptide dendrimers, Part III—a review: use of glycopeptide dendrimers in immunotherapy and diagnosis of cancer and viral diseases
Pieters et al. Application of the 1, 3‐Dipolar Cycloaddition Reaction in Chemical Biology: Approaches Toward Multivalent Carbohydrates and Peptides and Peptide‐Based Polymers
JP3181276B2 (ja) 樹枝状分岐構造を持つ両親媒性化合物
Shiao et al. Glycodendrimers as functional antigens and antitumor vaccines
EP0538230A1 (en) Method for producing synthetic N-linked glycoconjugates
DK1850832T3 (en) adjuvanting
AU2003224878B2 (en) Synthetic glyco-lipo-peptides as vaccines
FI66878B (fi) Foerfarande foer framstaellning av nya antigenderivat
US7531181B2 (en) Gp120 specific antigens and uses thereof
HU195620B (en) Process for producing conjugates with immunogenic effect and built up from haptenes and muramylpeptides and pharmaceutics comprising these conjugates
JPH11508564A (ja) 合成n−結合グリココンジュゲートを製造するための方法
Ribić et al. Advances in desmuramyl peptide research
JP2010540488A (ja) 糖タンパク質及びグリコシル化細胞及びそれらの調製方法
EP2407178A2 (en) Monovalent and polyvalent synthetic polysaccharide antigens for immunological intervention in disease
Hevey et al. Conjugation Strategies Used for the Preparation of Carbohydrate‐Conjugate Vaccines
Roy et al. Organic chemistry and immunochemical strategies in the design of potent carbohydrate-based vaccines
Kihlberg et al. Use of carbohydrates and peptides in studies of adhesion of pathogenic bacteria and in efforts to generate carbohydrate-specific T cells
JP2007527864A (ja) 自然に起こる化学的連結による、多官能化ペプチドおよび/またはタンパク質の調製方法
CN102282160B (zh) 多配体构成物
Fernandez-Santana et al. Conjugation of 5-azido-3-oxapentyl glycosides with thiolated proteins through the use of thiophilic derivatives
Vepřek Desing and synthesis of Tn-bearing glycodendrimers and their interaction with components of innate and adaptive immunity
CZ278551B6 (en) Polymeric medicament, process for preparing thereof and pharmaceutical compositions based thereon